GreenLight Biosciences (GRNAW) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    GreenLight Biosciences

    NASDAQ: GRNAW · Real-Time Price · USD
    0.02
    -0.00 (-0.99%)
    At close: Jul 21, 2023, 6:10 PM

    GreenLight Biosciences Balance Sheet Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 68.1M 31.45M
    Short-Term Investments
    		 n/a n/a
    Long-Term Investments
    		 n/a n/a
    Other Long-Term Assets
    		 3.16M 5.88M
    Receivables
    		 n/a n/a
    Inventory
    		 n/a n/a
    Other Current Assets
    		 3.21M 462.55K
    Total Current Assets
    		 71.31M 33.78M
    Property-Plant & Equipment
    		 74.13M 23.4M
    Goodwill & Intangibles
    		 n/a n/a
    Total Long-Term Assets
    		 77.29M 29.28M
    Total Assets
    		 148.6M 63.06M
    Account Payables
    		 839K 7.55M
    Deferred Revenue
    		 3.87M 963K
    Short-Term Debt
    		 16.59M 38.92M
    Other Current Liabilities
    		 14.27M 14.9M
    Total Current Liabilities
    		 35.56M 62.34M
    Long-Term Debt
    		 63.9M 27.15M
    Other Long-Term Liabilities
    		 1.08M 3.54M
    Total Long-Term Liabilities
    		 64.98M 30.69M
    Total Liabilities
    		 100.54M 93.03M
    Total Debt
    		 80.48M 66.08M
    Common Stock
    		 15K 10K
    Retained Earnings
    		 -420.64M -253.57M
    Comprehensive Income
    		 n/a n/a
    Shareholders Equity
    		 48.06M -29.98M
    Total Investments
    		 n/a n/a

    Add to Watchlist